• Investors

RegCell was selected as a pitch finalist for HVC Kyoto 2023

At HVC Kyoto 2023, an innovation platform specialized in the healthcare field, COO (Ishikawa) will pitch as pitch finalists to global pharmaceutical companies participating as advisors and partners, and will also have the opportunity to meet with them. The presentations will be given in English, so please be sure to register and watch the presentations.

Please see program details.